Despite the widespread prophylactic use of agents with antifungal properties, infections caused by pathogenic fungi are causing increasing mortality and morbidity in a variety of immunocompromised patients.The high recurrence has sparked growing concern among clinicians regarding the potential emergence of resistance among these opportunistic mycoses agents.